H.R. 3174

119th Congress

In Committee

Made in America Manufacturing Finance Act

Sponsored byRepublican:Rep. Williams, Roger [R-TX-25]TX· Introduced 1 mai 2025

12

Cosponsors

18

Actions

0

Amendments

3

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Committee on Small Business and Entrepreneurship. Hearings held.

13 mai 2026·2 months ago

Summary

Reported to House · Updated 23 avril 2026

Made in America Manufacturing Finance Act

This bill increases the maximum loan amounts available to small manufacturers under the Small Business Administration's 7(a) and 504 loan programs.

In particular, the bill generally doubles the maximum loan amount for small manufacturers under the 7(a) program and the bill increases the maximum loan amount for small manufacturers under the 504 program from $5.5 million to $10 million.

Generally, 7(a) loans provide short- and long-term working capital which can be used for expenses such as operational needs. 504 loans provide financing for major fixed assets such as new facilities.

Timeline

18 actions

  1. Committee on Small Business and Entrepreneurship. Hearings held.

    13 mai 2026 · Committee

  2. Senate vitiated previous action of 12/02/2025 by Unanimous Consent.

    4 décembre 2025 · Floor

  3. Senate vitiated previous action of 12/02/2025 by Unanimous Consent.

    4 décembre 2025 · Floor

  4. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 283.

    4 décembre 2025 · Calendars

  5. Received in the Senate and Read twice and referred to the Committee on Finance.

    2 décembre 2025 · IntroReferral

  6. Received in the Senate and Read twice and referred to the Committee on Finance.

    2 décembre 2025 · IntroReferral

  7. Considered under suspension of the rules. (consideration: CR H4912-4913)

    1 décembre 2025 · Floor

  8. DEBATE - The House proceeded with forty minutes of debate on H.R. 3174.

    1 décembre 2025 · Floor

  9. Mr. Williams (TX) moved to suspend the rules and pass the bill, as amended.

    1 décembre 2025 · Floor

  10. Mr. Williams (TX) moved to suspend the rules and pass the bill, as amended.

    1 décembre 2025 · Floor

  11. Motion to reconsider laid on the table Agreed to without objection.

    1 décembre 2025 · Floor

  12. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4912)

    1 décembre 2025 · Floor

  13. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4912)

    1 décembre 2025 · Floor

  14. Reported (Amended) by the Committee on Small Business. H. Rept. 119-224.

    15 août 2025 · Committee

  15. Reported (Amended) by the Committee on Small Business. H. Rept. 119-224.

    15 août 2025 · Committee

  16. Reported (Amended) by the Committee on Small Business. H. Rept. 119-224.

    15 août 2025 · Committee

  17. Placed on the Union Calendar, Calendar No. 182.

    15 août 2025 · Calendars

  18. Committee Consideration and Mark-up Session Held

    22 juillet 2025 · Committee

  19. Committee Consideration and Mark-up Session Held

    22 juillet 2025 · Committee

  20. Ordered to be Reported (Amended) by Voice Vote.

    22 juillet 2025 · Committee

Sponsorship

12 cosponsors

Sponsor

Republican:Rep. Williams, Roger [R-TX-25]TX

Cosponsors

  • Republican12100%

Classification

Policy area

Commerce

Legislative subjects

Government lending and loan guaranteesManufacturingSmall business

Committees

3

  • Small Business Committee

    House · Standing

    • Referred To1 May 2025
    • Markup By22 Jul 2025
    • Reported By15 Aug 2025
  • Finance Committee

    Senate · Standing

    • Referred To2 Dec 2025
  • Small Business and Entrepreneurship Committee

    Senate · Standing

    • Hearings By (full committee)13 May 2026

Cosponsor momentum

Cumulative over time

Cosponsors grew from 0 on 1 mai 2025 to 12 on 22 juillet 2025.

Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.